Related Experiment Video
Updated: Jan 7, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Patient-Centred Gestational Diabetes Care: Preference Elicitation Methods and Machine Learning Innovations
Shaikha Alharmoodi1, Mariam Al Nweran1, Imad El-Kebbi2
1Department of Public Health and Epidemiology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.
Abstract:
Gestational Diabetes Mellitus (GDM) requires long-term management, frequent visits, and additional financial costs compared to normal pregnancies. Patients often express preferences for services that save time, reduce expenses, and simplify screening. Virtual and telehealth services are valued as they shorten travel and waiting times, lower costs, and improve satisfaction. Screening preferences emphasize accuracy, affordability, and convenience, while recent machine learning (ML) models have enhanced prediction and early detection, supporting more personalized strategies. Patients' preferences have been explored through qualitative, quantitative, and mixed methods, which capture lived experiences, quantify trade-offs, and contextualize results. This review aims to examine GDM patients' experiences with time, costs, and screening, highlight the role of machine learning in screening, and synthesize evidence from preference-elicitation methods to inform patient-centred care. By linking patient preferences with technological advances in ML, this review provides a broader and more integrated perspective than previous reviews, helping to guide future GDM research and service design.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

